% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Guo:168678,
author = {F. Guo$^*$ and C. Chen$^*$ and B. Holleczek and B.
Schöttker$^*$ and M. Hoffmeister$^*$ and H. Brenner$^*$},
title = {{S}trong {R}eduction of {C}olorectal {C}ancer {I}ncidence
and {M}ortality {A}fter {S}creening {C}olonoscopy:
{P}rospective {C}ohort {S}tudy {F}rom {G}ermany.},
journal = {The American journal of gastroenterology},
volume = {116},
number = {5},
issn = {1572-0241},
address = {Alphen aan den Rijn, The Netherlands},
publisher = {Wolters Kluwer Health, Inc.},
reportid = {DKFZ-2021-00986},
pages = {967 - 975},
year = {2021},
note = {#EA:C070#LA:C070#},
abstract = {A claimed advantage of colonoscopy over sigmoidoscopy in
colorectal cancer (CRC) screening is prevention of CRC not
only in the distal colon and rectum but also in the proximal
colon. We aimed to assess the association of screening
colonoscopy use with overall and site-specific CRC incidence
and associated mortality.Information on use of screening
colonoscopy as well as potential confounding factors was
obtained at baseline in 2000-2002, updated at 2-, 5-, 8-,
and 17-year follow-up from 9,207 participants aged 50-75
years without history of CRC in a statewide cohort study in
Saarland, Germany. Covariate-adjusted associations of
screening colonoscopy with CRC incidence and mortality,
which were obtained through record linkage with the Saarland
Cancer Registry and mortality statistics up to 2018, were
assessed by Cox proportional hazards models with
time-varying exposure information.During a median follow-up
of 17.2 years, 268 participants were diagnosed with CRC and
98 died from CRC. Screening colonoscopy was associated with
strongly reduced CRC incidence (adjusted hazard ratio [aHR]
0.44, $95\%$ confidence interval [CI] 0.33-0.57) and
mortality (aHR 0.34, $95\%$ CI 0.21-0.53), with stronger
reduction for distal (aHRs 0.36, $95\%$ CI 0.25-0.51, and
0.33, $95\%$ CI 0.19-0.59, respectively) than for proximal
cancer (aHRs 0.69, $95\%$ CI 0.42-1.13, and 0.62, $95\%$ CI
0.26-1.45, respectively). Nevertheless, strong reduction of
mortality from proximal cancer was also observed within 10
years after screening colonoscopy (aHR 0.31, $95\%$ CI
0.10-0.96).In this large prospective cohort study from
Germany, screening colonoscopy was associated with strong
reduction in CRC incidence and mortality.},
cin = {C070 / C120 / HD01},
ddc = {610},
cid = {I:(DE-He78)C070-20160331 / I:(DE-He78)C120-20160331 /
I:(DE-He78)HD01-20160331},
pnm = {313 - Krebsrisikofaktoren und Prävention (POF4-313)},
pid = {G:(DE-HGF)POF4-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:33929378},
doi = {10.14309/ajg.0000000000001146},
url = {https://inrepo02.dkfz.de/record/168678},
}